q9 online casino

q9 online casino Solana’s Record-Breaking Performance Amidst Memecoin ManiaNoneW. R. Berkley Corporation Declares Special and Regular Quarterly Cash DividendsKHAN YOUNIS, Gaza Strip (AP) — Israeli airstrikes tore through a tent camp for displaced Palestinians in southern Gaza on Wednesday, sparking fires and killing at least 21 people, according to the head of a nearby hospital, in the latest assault on a sprawling tent city that Israel designated a humanitarian safe zone but has repeatedly targeted. The Israeli military said it struck senior Hamas militants “involved in terrorist activities” in the area, without providing additional details, and said it took precautions to minimize harm to civilians. The strike on the Muwasi tent camp was one of several deadly assaults across the Gaza Strip on Wednesday. An Israeli attack in central Gaza killed at least 10 more people, including four children, according to Palestinian medics. Israel’s devastating war in Gaza , launched after Hamas’ October 2023 attack, shows no signs of ending after nearly 14 months. Hamas is still holding dozens of Israeli hostages, and most of Gaza’s population has been displaced and is reliant on international food aid to survive. Israel is also pressing a major offensive in the isolated north, where experts say Palestinians might be experiencing famine . The Biden administration has pledged to make a new push for a Gaza ceasefire now that there's a truce in Lebanon between Israel and the militant group Hezbollah, ending more than a year of cross-border fighting. Meanwhile, President-elect Donald Trump demanded this week the release of hostages held by Hamas before he is sworn into office in January. Wednesday's strike in Muwasi — a desolate area with few public services that holds hundreds of thousands of displaced people — wounded at least 28 people, according to Atif al-Hout, the director of Nasser Hospital in the southern city of Khan Younis. An Associated Press journalist at the hospital counted at least 15 bodies, but said reaching a precise number was difficult because many of the dead were dismembered, some without heads or badly burned. In the morgue, an infant's blackened hand and face peeked out from beneath a heavy blanket used to transport bodies to the hospital. “It was like doomsday,” said a wounded woman, Iman Jumaa, who held back tears as she described how the strike killed her father, her brothers and her brothers' children. Videos and photos of the strike shared widely on social media showed flames and a column of black smoke rising into the night sky, as well as twisted metal tent frames and shredded fabric. Palestinian men searched through the still-burning wreckage, shouting, “Over here guys!” Further away, civilians stood at a distance, observing the destruction. The military said the strikes had set off secondary blasts, indicating explosives present in the area had detonated. It was not possible to independently confirm the Israeli claims, and the strikes could also have ignited fuel, cooking gas canisters or other materials in the camp. Shortly after the strike, Al-Awda Hospital said two people had been killed and 38 wounded in an attack on a residential block in the Nuseirat refugee camp. The military had no immediate comment on the strike, but said earlier strikes in central Gaza had hit “terrorist targets." Israel says it tries to avoid harming civilians and blames Hamas for their deaths, saying the militants often operate in residential areas and are known to position tunnels, rocket launchers and other infrastructure near homes, schools and mosques. Previous Israeli strikes on tent camps in Gaza have drawn widespread international outrage, such as when a wounded student’s last moments were caught on video as he burned to death in a tent outside a hospital. In northern Gaza, dozens of Palestinian families said Israel's expanding offensive had forcibly displaced them from schools-turned-shelters. Associated Press footage showed people on the road Wednesday leaving Beit Lahia, many crowded onto donkey carts with their belongings in their arms. Others walked on foot. “This morning a quadcopter (drone) detonated four bombs at the school. There were people injured, human remains — we left with nothing,” said Sadeia al-Rahel. The 57-year-old said her family has been eating grass, leaves, and animal feed for two months due to the lack of food aid in the north. The amount of aid entering Gaza plunged in October, and hunger is widespread across the territory, even in central Gaza where aid groups have more access. Humanitarian organizations say Israeli restrictions, ongoing fighting and the breakdown of law and order make it difficult to deliver assistance. Israel has said it is working to increase the flow of aid. Israel’s offensive has killed over 44,500 Palestinians in Gaza, mostly women and children, according to the Gaza Health Ministry, which does not say how many were combatants. The Israeli military says it has killed over 17,000 militants, without providing evidence. The Oct. 7, 2023 Hamas-led attack on southern Israel killed some 1,200 people, mostly civilians, and around 250 people were abducted. Some 100 hostages are still inside Gaza, at least a third of whom are believed to be dead. On Wednesday, Israel said its forces recovered the body of a hostage who was captured alive during the Oct. 7 attack. Israel believes Itay Svirsky was killed by his captors. The families of hostages held in Gaza have grown increasingly concerned that their loved ones are at risk so long as the war continues. Israel’s military released on Wednesday the findings of a probe into the circumstances behind the deaths of six hostages whose bodies were recovered in August, determining they were probably shot by their captors after a nearby Israeli strike in February. Shurafa reported from Deir al-Balah, Gaza Strip. Associated Press writer Tia Goldenberg in Jerusalem contributed to this report. Follow AP’s war coverage at https://apnews.com/hub/mideast-wars

Gulf Bank holds ‘Movember’ campaign to raise awareness about men’s health

None

Stock Markets Extends Record Highs, US Labor Market Recovers, Bitcoin Hits $100,000: This Week In The MarketsNatixis Advisors LLC Grows Holdings in UMB Financial Co. (NASDAQ:UMBF)

Some versions of 2026 Hyundai Palisade will fit 9 passengersSupreme Court seems likely to uphold Tennessee's ban on medical treatments for transgender minors

QUYSC marks completion of semester programmesNebraska governor’s priorities shift focus from spending and tax changes

Trump is hiding donors' names as he rakes in 'secret money': NYTCatch all the action as a basketball doubleheader between the Fergus Falls Otters and the Moorhead Spuds takes place Tuesday, Dec. 3 on WDAY Xtra. The girls game tips off at 6 p.m. and the boys face off at 7:30 p.m. You can catch all the action on WDAY Xtra or streaming online at Inforum.com. SUBSCRIPTION RATES & PLANS WDAY Sports+ is available for $9.99 per month or $100 per year and also includes access to weekly high school games in North Dakota and western Minnesota and games involving Minnesota State University Moorhead. Subscribers outside of the WDAY-TV broadcast footprint will not be able to access Bison games live but can watch them on the site after they conclude. SUBSCRIBE HERE : https://inforum.com/wdayplus ** Note: If you have an existing news subscription, you will need a separate livestream subscription to access this content **

GSA Capital Partners LLP bought a new position in Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA – Free Report ) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,729 shares of the company’s stock, valued at approximately $268,000. Several other hedge funds and other institutional investors also recently modified their holdings of KNSA. CWM LLC boosted its stake in Kiniksa Pharmaceuticals by 443.0% in the 3rd quarter. CWM LLC now owns 2,449 shares of the company’s stock worth $61,000 after purchasing an additional 1,998 shares during the period. nVerses Capital LLC bought a new position in shares of Kiniksa Pharmaceuticals in the third quarter valued at approximately $80,000. Lazard Asset Management LLC purchased a new position in Kiniksa Pharmaceuticals during the first quarter valued at approximately $71,000. Ashton Thomas Private Wealth LLC bought a new stake in Kiniksa Pharmaceuticals during the 2nd quarter worth approximately $100,000. Finally, China Universal Asset Management Co. Ltd. lifted its stake in Kiniksa Pharmaceuticals by 65.0% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 7,810 shares of the company’s stock worth $195,000 after purchasing an additional 3,076 shares in the last quarter. Institutional investors own 53.95% of the company’s stock. Analyst Upgrades and Downgrades Several equities analysts recently commented on the company. Jefferies Financial Group assumed coverage on Kiniksa Pharmaceuticals in a research report on Friday, September 13th. They set a “buy” rating and a $40.00 target price for the company. Evercore ISI raised their target price on shares of Kiniksa Pharmaceuticals from $30.00 to $35.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Kiniksa Pharmaceuticals from $39.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, Kiniksa Pharmaceuticals has an average rating of “Buy” and a consensus target price of $36.60. Insider Activity In related news, insider John F. Paolini sold 60,692 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $26.12, for a total transaction of $1,585,275.04. Following the sale, the insider now owns 52,038 shares of the company’s stock, valued at $1,359,232.56. This represents a 53.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link . Also, COO Eben Tessari sold 17,000 shares of Kiniksa Pharmaceuticals stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $26.87, for a total value of $456,790.00. Following the completion of the transaction, the chief operating officer now owns 109,975 shares of the company’s stock, valued at approximately $2,955,028.25. This represents a 13.39 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold 112,692 shares of company stock worth $2,950,315 in the last three months. Company insiders own 54.57% of the company’s stock. Kiniksa Pharmaceuticals Trading Up 0.9 % Shares of KNSA opened at $21.28 on Friday. The company has a market cap of $1.54 billion, a price-to-earnings ratio of -152.00 and a beta of 0.35. The business’s fifty day simple moving average is $24.29 and its two-hundred day simple moving average is $22.88. Kiniksa Pharmaceuticals, Ltd. has a 12 month low of $15.52 and a 12 month high of $28.15. Kiniksa Pharmaceuticals ( NASDAQ:KNSA – Get Free Report ) last announced its earnings results on Tuesday, October 29th. The company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.17). The company had revenue of $112.21 million for the quarter, compared to analysts’ expectations of $111.51 million. Kiniksa Pharmaceuticals had a negative net margin of 2.36% and a negative return on equity of 7.31%. Kiniksa Pharmaceuticals’s quarterly revenue was up 67.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.20) earnings per share. As a group, research analysts forecast that Kiniksa Pharmaceuticals, Ltd. will post -0.55 EPS for the current year. About Kiniksa Pharmaceuticals ( Free Report ) Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. See Also Five stocks we like better than Kiniksa Pharmaceuticals Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness Vertiv’s Cool Tech Makes Its Stock Red-Hot Golden Cross Stocks: Pattern, Examples and Charts MarketBeat Week in Review – 11/18 – 11/22 What is the S&P/TSX Index? 2 Finance Stocks With Competitive Advantages You Can’t Ignore Receive News & Ratings for Kiniksa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kiniksa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .

Eagle-eyed viewers spot Tulisa was eager to remove 'all traces' of I'm A Celeb

Man accused of duping churchgoers into investing in video Covid-test tech to plead guiltyBuffalo-Based Ed-Tech Startup Sees Growth Through Partnerships

The former Tory chancellor, now chairman of the British Museum, suggested Sir Keir Starmer had contributed to a warmer spirit of the negotiations over the famous ancient artworks. Greece has long called for the return of the Marbles, also known as the Parthenon sculptures, and maintains they were illegally removed from Athens’ acropolis during a period of foreign occupation. The British Museum – where they are currently on display – is forbidden by law from giving away any of its artefacts, and the Government has no plans to change the law to permit a permanent move. But under Mr Osborne’s leadership, the museum is negotiating the possibility of a long-term loan of the sculptures, in exchange for rolling exhibitions of famous artworks. No 10 has indicated the Prime Minister is unlikely to stand in the way of such a deal. Speaking on Political Currency, the podcast he hosts alongside former Labour politician Ed Balls, Mr Osborne said the museum was “looking to see if we can come to some arrangement where at some point some of the sculptures are in Athens, where, of course, they were originally sited”. He added: “And in return, Greece lends us some of its treasures, and we made a lot of progress on that, but we’re still some distance from any kind of agreement.” The Greek government has suggested negotiations with the museum have taken a warmer tone since Labour came to power in the summer. Mr Osborne appeared to concur with this view and praised Sir Keir’s hands-off approach, adding: “It is not the same as Rishi Sunak, who refused to see the Greek prime minister, if you remember, he sort of stood him up. “So it seems to me a more sensible and diplomatic way to proceed.” Kyriakos Mitsotakis, the Greek premier, discussed the Elgin Marbles with Sir Keir when they met on Tuesday morning at Downing Street, he said after returning to Athens. Mr Mitsotakis has signalled his government is awaiting developments on the negotiations. A diplomatic spat between the Greek leader and Mr Sunak emerged last year when the then-prime minister refused to meet his counterpart. Mr Mitsotakis had compared splitting the Elgin Marbles from those still in Athens to cutting the Mona Lisa in half. The marble statues came from friezes on the 2,500-year-old Parthenon temple and have been displayed at the British Museum for more than 200 years. They were removed by Lord Elgin in the early 19th century when he was British ambassador to the Ottoman Empire. Some of the remaining temple statues are on display in the purpose-built Acropolis Museum in Athens, and Greece has called for the collections to be reunited.BridgingApps® and Sentara Health Plans Creating Transition Tool for Children and Youth with Special Health Needs